Titre : AlkB enzymes

AlkB enzymes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Disorders of Excessive Somnolence
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "AlkB enzymes : Questions médicales les plus fréquentes", "headline": "AlkB enzymes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les AlkB enzymes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "AlkB enzymes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dioxygenases", "url": "https://questionsmedicales.fr/mesh/D049308", "about": { "@type": "MedicalCondition", "name": "Dioxygenases", "code": { "@type": "MedicalCode", "code": "D049308", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "AlkB Homolog 1, histone H2a dioxygenase", "alternateName": "AlkB Homolog 1, Histone H2a Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D000071498", "about": { "@type": "MedicalCondition", "name": "AlkB Homolog 1, histone H2a dioxygenase", "code": { "@type": "MedicalCode", "code": "D000071498", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.500" } } }, { "@type": "MedicalWebPage", "name": "AlkB Homolog 2, alpha-ketoglutarate-dependent dioxygenase", "alternateName": "AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D000071499", "about": { "@type": "MedicalCondition", "name": "AlkB Homolog 2, alpha-ketoglutarate-dependent dioxygenase", "code": { "@type": "MedicalCode", "code": "D000071499", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.750" } } }, { "@type": "MedicalWebPage", "name": "AlkB Homolog 3, alpha-ketoglutarate-dependent dioxygenase", "alternateName": "AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D000071500", "about": { "@type": "MedicalCondition", "name": "AlkB Homolog 3, alpha-ketoglutarate-dependent dioxygenase", "code": { "@type": "MedicalCode", "code": "D000071500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.875" } } }, { "@type": "MedicalWebPage", "name": "AlkB Homolog 4, lysine demethylase", "alternateName": "AlkB Homolog 4, Lysine Demethylase", "url": "https://questionsmedicales.fr/mesh/D000071501", "about": { "@type": "MedicalCondition", "name": "AlkB Homolog 4, lysine demethylase", "code": { "@type": "MedicalCode", "code": "D000071501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.937" } } }, { "@type": "MedicalWebPage", "name": "AlkB Homolog 5, RNA demethylase", "alternateName": "AlkB Homolog 5, RNA Demethylase", "url": "https://questionsmedicales.fr/mesh/D000071502", "about": { "@type": "MedicalCondition", "name": "AlkB Homolog 5, RNA demethylase", "code": { "@type": "MedicalCode", "code": "D000071502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.968" } } }, { "@type": "MedicalWebPage", "name": "Alpha-ketoglutarate-dependent dioxygenase FTO", "alternateName": "Alpha-Ketoglutarate-Dependent Dioxygenase FTO", "url": "https://questionsmedicales.fr/mesh/D000071516", "about": { "@type": "MedicalCondition", "name": "Alpha-ketoglutarate-dependent dioxygenase FTO", "code": { "@type": "MedicalCode", "code": "D000071516", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416.139.992" } } } ], "about": { "@type": "MedicalCondition", "name": "AlkB enzymes", "alternateName": "AlkB Enzymes", "code": { "@type": "MedicalCode", "code": "D000071496", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Shoshana C Williams", "url": "https://questionsmedicales.fr/author/Shoshana%20C%20Williams", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Barnard College, 3009 Broadway, New York, NY, 10027, USA." } }, { "@type": "Person", "name": "Rachel Narehood Austin", "url": "https://questionsmedicales.fr/author/Rachel%20Narehood%20Austin", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Barnard College, 3009 Broadway, New York, NY, 10027, USA. raustin@barnard.edu." } }, { "@type": "Person", "name": "Deyu Li", "url": "https://questionsmedicales.fr/author/Deyu%20Li", "affiliation": { "@type": "Organization", "name": "Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA." } }, { "@type": "Person", "name": "Zhijie Xu", "url": "https://questionsmedicales.fr/author/Zhijie%20Xu", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China." } }, { "@type": "Person", "name": "Juliet Lee", "url": "https://questionsmedicales.fr/author/Juliet%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Barnard College, 3009 Broadway, New York, NY, 10027, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Excessive daytime sleepiness in nursing technicians: association with sleep quality and memory.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39082540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0034-7167-2023-0332" } }, { "@type": "ScholarlyArticle", "name": "Effect of insomnia and excessive daytime sleepiness on cardiac functions in older adults.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37414531", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/psyg.12999" } }, { "@type": "ScholarlyArticle", "name": "Sex differences in variables associated with excessive daytime sleepiness in patients with epilepsy.", "datePublished": "2022-12-05", "url": "https://questionsmedicales.fr/article/36473303", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.yebeh.2022.109015" } }, { "@type": "ScholarlyArticle", "name": "[A somnolent man].", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36036692", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea.", "datePublished": "2023-10-17", "url": "https://questionsmedicales.fr/article/37847434", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40263-023-01040-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "Oxygénases", "item": "https://questionsmedicales.fr/mesh/D010105" }, { "@type": "ListItem", "position": 6, "name": "Dioxygenases", "item": "https://questionsmedicales.fr/mesh/D049308" }, { "@type": "ListItem", "position": 7, "name": "AlkB enzymes", "item": "https://questionsmedicales.fr/mesh/D000071496" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : AlkB enzymes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur AlkB enzymes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur AlkB enzymes", "description": "Comment diagnostiquer une déficience en enzymes AlkB ?\nQuels tests sont utilisés pour évaluer l'activité des enzymes AlkB ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec les enzymes AlkB ?\nY a-t-il des marqueurs biologiques pour les enzymes AlkB ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur AlkB enzymes", "description": "Quels sont les symptômes d'une déficience en AlkB ?\nLes symptômes varient-ils selon le type d'AlkB ?\nComment les symptômes évoluent-ils avec l'âge ?\nY a-t-il des symptômes spécifiques liés au cancer ?\nLes symptômes sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur AlkB enzymes", "description": "Peut-on prévenir les déficiences en AlkB ?\nY a-t-il des recommandations diététiques ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nL'éducation sur les risques est-elle importante ?\nLes vaccinations peuvent-elles jouer un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur AlkB enzymes", "description": "Quels traitements existent pour les déficiences en AlkB ?\nLa supplémentation en nutriments aide-t-elle ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des essais cliniques en cours ?\nLes traitements sont-ils efficaces à long terme ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur AlkB enzymes", "description": "Quelles complications peuvent survenir avec une déficience en AlkB ?\nLes complications sont-elles réversibles ?\nY a-t-il des complications liées à des traitements ?\nLes complications varient-elles selon l'âge ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur AlkB enzymes", "description": "Quels sont les principaux facteurs de risque pour les déficiences en AlkB ?\nL'environnement joue-t-il un rôle ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nY a-t-il des groupes à risque particulier ?", "url": "https://questionsmedicales.fr/mesh/D000071496?mesh_terms=Disorders+of+Excessive+Somnolence&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en enzymes AlkB ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses biochimiques peuvent être utilisés pour diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des enzymes AlkB ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques spécifiques et des analyses de métabolites peuvent être réalisés." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais elles peuvent être utiles pour évaluer des tissus spécifiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les enzymes AlkB ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la réparation de l'ADN, pouvant mener à des cancers ou des maladies génétiques." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les enzymes AlkB ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs peuvent indiquer l'activité ou la déficience des enzymes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en AlkB ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des anomalies de croissance, des troubles neurologiques et un risque accru de cancer." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'AlkB ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types d'AlkB peuvent entraîner des symptômes variés selon leur fonction." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec l'âge, surtout en cas d'exposition à des agents alkylants." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques liés au cancer ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue, la perte de poids et des douleurs peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes sont-ils réversibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certains symptômes peuvent être gérés, mais d'autres peuvent être permanents selon la gravité." } }, { "@type": "Question", "name": "Peut-on prévenir les déficiences en AlkB ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais éviter les agents alkylants peut réduire les risques." } }, { "@type": "Question", "name": "Y a-t-il des recommandations diététiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut aider à protéger l'ADN contre les dommages." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque et permettre une surveillance précoce." } }, { "@type": "Question", "name": "L'éducation sur les risques est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sensibiliser aux risques liés aux agents alkylants est crucial pour la prévention." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles jouer un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les déficiences en AlkB." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en AlkB ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie génique et des médicaments ciblés pour améliorer la réparation de l'ADN." } }, { "@type": "Question", "name": "La supplémentation en nutriments aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que des antioxydants peuvent aider à réduire les dommages à l'ADN." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction du type de déficience et des symptômes." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques en cours ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs essais cliniques explorent de nouvelles thérapies pour les déficiences en AlkB." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces à long terme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité varie, mais certains traitements montrent des résultats prometteurs sur le long terme." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en AlkB ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent un risque accru de cancers et des troubles neurologiques graves." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Y a-t-il des complications liées à des traitements ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements peuvent entraîner des effets secondaires et des complications." } }, { "@type": "Question", "name": "Les complications varient-elles selon l'âge ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent être plus graves chez les personnes âgées ou immunodéprimées." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de dépistage peuvent aider à surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les déficiences en AlkB ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques et l'exposition à des agents alkylants." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des produits chimiques et à des radiations peut augmenter le risque." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers ou de maladies génétiques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque particulier ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes exposées à des agents chimiques au travail sont à risque accru." } } ] } ] }

Sources (10000 au total)

Excessive daytime sleepiness in nursing technicians: association with sleep quality and memory.

to investigate excessive daytime sleepiness prevalence among nursing technicians and the association with sleep quality and memory.... a cross-sectional, inferential study, carried out in a hospital unit in the state of Goiás between December 2020 and January 2021. Assessments were carried out using the Epworth Sleepiness Scale, the ... the sample consisted of 189 nursing technicians with a 40.9% excessive daytime sleepiness prevalence. In multivariate models, excessive daytime sleepiness was not associated with sleep quality, howeve... study results demonstrate a high excessive daytime sleepiness occurrence, an association with overall memory failures and the need for psychosocial interventions for nursing technicians....

Effect of insomnia and excessive daytime sleepiness on cardiac functions in older adults.

We investigated the potential harmful effect in older adults of insomnia and excessive daytime sleepiness (EDS) on myocardial functions and electrophysiologic changes of the heart in terms of heart ra... The study included 32 insomnia patients and 30 control subjects. An Insomnia Severity Index score of ≥15 indicated insomnia, while a score of <8 was accepted as the control group. The Epworth Sleepine... The mean age was 73.2 ± 7.9 years, with 59.7% being female. Biventricular systolic and diastolic functions were impaired in the insomnia patients. The E' value for diastolic function was lower in the ... Insomnia is associated with impaired systolic-diastolic functions, independent of EDS. The co-existence of insomnia and EDS may lead to electrophysiological changes in older adults, including increase...

Sex differences in variables associated with excessive daytime sleepiness in patients with epilepsy.

Excessive daytime sleepiness (EDS) is common in patients with epilepsy (PWE). The Epworth Sleepiness Scale (ESS) is a self-reported measure of sleepiness in widespread use. The purpose of this study w... A cross-sectional study was performed on 115 PWE presenting to the epilepsy clinic. Self-reported questionnaires were administered and demographic and clinical information was gathered from the electr... A high ESS score was found in nearly 20% of the cohort. Obstructive sleep apnea (OSA) risk, standardized anti-seizure drug (ASD) dose, and female sex were associated with an increased likelihood of a ... Sex is likely to be a key factor in determining contributors to EDS in PWE....

Quality of sleep and excessive daytime sleepiness among medical students in a Brazilian private university.

The aim of this study was to assess medical students' quality of sleep and excessive daytime sleepiness in different graduation cycles.... A cross-sectional study was carried out at a private university in Maceió, Brazil, from August 2021 to March 2022. The sample was composed of medical students aged 18 years and above from years 1-2 (b... A total of 179 students participated; most of them were female (78.2%), aged 19-25 years (73.7%), and with a body mass index<25 kg/m2 (73.7%), with smaller participation from students from the basic c... About half of the medical students experience poor sleep quality and daytime sleepiness, regardless of the graduation cycle. This should trigger a targeted institutional intervention to promote better...

Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.

Facioscapulohumeral muscular dystrophy (FSHD) causes weakness and secondary associations, such as respiratory complications and pain, that can be linked to abnormal sleep patterns. Limited studies hav... We conducted a prospective survey of individuals with self-reported FSHD enrolled in the FSHD Society Registry. The survey consisted of demographic and clinical characteristics, the Pittsburgh Sleep Q... Six hundred ninety individuals responded to the survey, equally distributed between men and women, and spanning the age range from under 12 to 74 years of age or older. Sixty-six percent of the respon... Physicians should monitor sleep quality of patients with FSHD as a routine part of care, with special attention to potentially modifiable factors. Future research should address the physiological effe...

Excessive Daytime Sleepiness in Parkinson's Disease is Related to Functional Abnormalities in the Left Angular Gyrus.

Excessive daytime sleepiness (EDS) is a common non-motor symptom in Parkinson's disease (PD), but its neuropathology remains elusive. Our goal is to explore the potential neural substrates of EDS in a... We recruited 48 PD patients with and 87 PD patients without EDS. We used resting-state functional magnetic resonance imaging to compare amplitudes of low-frequency fluctuations (ALFF) between the two ... EDS was associated with significantly lower ALFF in the left angular gyrus, and ALFF in this region correlated negatively with score on the Epworth Sleepiness Scale in patients with PD. EDS was also a... Our results suggest that EDS in PD patients is associated with reduced spontaneous neural activity in the left angular gyrus and with reduced FC between the left angular gyrus and cerebellum. These fi...

Links between excessive daytime sleepiness and EEG power and activation in two subtypes of ADHD.

This study aimed to replicate previously reported EEG characteristics between typically developing (TD) children and two subtypes of Attention Deficit Hyperactivity Disorder (ADHD) using a frontal, si... Children with ADHD Inattentive (ADHD-I) and ADHD Combined presentation (ADHD-C) and typically-developing (TD) children (N = 34 in each group) had frontal EEG recorded during eyes-closed resting, eyes-... Consistent with previous literature, there were increases in frontal delta and theta power in the ADHD-C compared to ADHD-I and TD groups, in all conditions. Novel power and activation effects in ADHD... These findings highlight the importance of considering ADHD subtypes and EDS when exploring EEG characteristics, and have important implications for the diagnosis and treatment of children with ADHD....